you d actually expect all the candidates to be pretty aggressively hawkish on russia, particularly after russia had just invaded one of their neighbors. but it was interesting. in that senate primary, that republican senate primary in 2014, this one primary candidate, the local talk radio host, he really went the other way. he called himself a former pentagon expert on russia and he told radio iowa that, quote, pushing the russians out of crimea is not a realistic option. he said, quote, i think a lot of people, i m not sure they understand the history of russia. you go back, you know, 1,500 years to the foundation of the russian empire. it actually started in ukraine and was evolved out of that. this whole issue is about as russian as it gets, meaning russia should be allowed to take parts of ukraine. that s russia s business, not anybody else s. and this candidate apparently felt pretty passionately about it. he went on in some detail,
carter page also turns up in the indictment o
live from berlin up next turning toxic and t w documentary film about the merger of the chemical groups by air and monsanto for the latest news don t forget you can always get it on our website at the t w dot com and you can follow news and myself on social media mining sarah cali thanks for watching have a great day. and i m dave i m with the brand new delusions on the spokes person device of the topics that affect us all water pollution climate change in the return of. only dream fans check it out.
they are a german corporate heavyweight under pressure and $21000.00 its blockbuster merger with u.s. rival monsanto has seemingly backfired it s facing one of the deepest crises in its 155 year history. of bowman s unfortunates christabel mon and his colleagues on the board miscalculated the risks they should have said no the deal is off to do research on that at the center of the controversy the weed killer roundup and its active ingredient life a sick did monsanto conceal the health
TG Therapeutics (NASDAQ:TGTX – Free Report) had its price objective increased by HC Wainwright from $45.00 to $49.00 in a research report report published on Thursday morning, Benzinga reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. Several other analysts have also recently issued reports on the stock. The Goldman Sachs […]
TG Therapeutics (NASDAQ:TGTX – Get Free Report) released its quarterly earnings data on Wednesday. The biopharmaceutical company reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.02), Briefing.com reports. The company had revenue of $63.47 million during the quarter, compared to analyst estimates of $54.60 million. TG Therapeutics had a net […]
TG Therapeutics, Inc. (NASDAQ:TGTX – Get Free Report) was the target of some unusual options trading activity on Wednesday. Stock investors acquired 13,983 call options on the stock. This is an increase of approximately 88% compared to the average volume of 7,433 call options. Insider Activity In related news, Director Laurence N. Charney sold 22,000 […]